These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15105895)

  • 1. [Production and examination of double antigen specific immunoserum for immunochemical detection of occult blood].
    Sz Németh M; Ottó S
    Magy Onkol; 2004; 48(1):45-7. PubMed ID: 15105895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
    Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Fletcher RH; Ransohoff DF; Imperiale TF
    Cancer; 2007 May; 109(9):1925-6; author reply 1926. PubMed ID: 17370313
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fecal oncomarkers in the diagnostics of colorectal cancer].
    Mikhaĭlova EI; Pimanov SI; Voropaev EV
    Klin Med (Mosk); 2007; 85(12):62-7. PubMed ID: 18318171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small benefit of many feces-Hb tests. Low diagnostic value of the immunochemical method according to a primary health care study].
    Högberg C; Asplund R
    Lakartidningen; 2010 May 26-Jun 1; 107(21):1372-5. PubMed ID: 20645610
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunochemical detection of human blood in feces.
    Barrows GH; Burton RM; Jarrett DD; Russell GG; Alford MD; Songster CL
    Am J Clin Pathol; 1978 Mar; 69(3):342-6. PubMed ID: 416710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of conventional guaiac to four immunochemical methods for fecal occult blood testing: implications for clinical practice in hospital and outpatient settings.
    Tannous B; Lee-Lewandrowski E; Sharples C; Brugge W; Bigatello L; Thompson T; Benzer T; Lewandrowski K
    Clin Chim Acta; 2009 Feb; 400(1-2):120-2. PubMed ID: 19000907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive testing for colorectal cancer: a review.
    Ouyang DL; Chen JJ; Getzenberg RH; Schoen RE
    Am J Gastroenterol; 2005 Jun; 100(6):1393-403. PubMed ID: 15929776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Lohsiriwat V; Thavichaigarn P; Awapittaya B
    J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance.
    van Roon AH; Wilschut JA; Hol L; van Ballegooijen M; Reijerink JC; 't Mannetje H; Kranenburg LJ; Biermann K; van Vuuren AJ; Francke J; van der Togt AC; Habbema DJ; van Leerdam ME; Kuipers EJ
    Clin Gastroenterol Hepatol; 2011 Apr; 9(4):333-9. PubMed ID: 21185397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.